Results 241 to 250 of about 68,267 (269)

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

New England Journal of Medicine, 2017
Johannes Oldenburg, Christophe Schmitt, Guy Young   +2 more
exaly  

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

New England Journal of Medicine, 2014
Michael Recht, Federico Mingozzi, Katherine A High   +2 more
exaly  

Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

New England Journal of Medicine, 2011
Edward Tuddenham, Savita Rangarajan, James O'Beirne   +2 more
exaly  

Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A

New England Journal of Medicine, 2016
Midori Shima, Koichiro Yoneyama, Hiroki Yoshida   +2 more
exaly  

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

New England Journal of Medicine, 2020
Barbara A Konkle, Janice M Staber, Roshni Kulkarni   +2 more
exaly  

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

New England Journal of Medicine, 2016
Flora Peyvandi, Isabella Garagiola, Amal El-Beshlawy   +2 more
exaly  

AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

New England Journal of Medicine, 2017
Savita Rangarajan, Will Lester, Michael Laffan   +2 more
exaly  

Sporadic Hemophilia

Archives of Internal Medicine, 1960
openaire   +2 more sources

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

New England Journal of Medicine, 2017
Savita Rangarajan, Pencho Georgiev, Margaret Ragni   +2 more
exaly  

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

Nature Medicine, 2015
Husain Attarwala, Stuart Milstein, Muthiah Manoharan   +2 more
exaly